2JMV | pdb_00002jmv

Solution structure of scytovirin refined against residual dipolar couplings

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
2	3D HNCACB	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
3	3D CBCA(CO)NH	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
4	3D HNCO	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
5	3D H(CCO)NH	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
6	3D C(CO)NH	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
7	3D HCCH-TOCSY	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
8	3D 1H-15N NOESY	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
9	3D 1H-13C NOESY	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15
10	jmod RDCs	0.5 mM [U-99% 13C; U-99% 15N] scytovirin, 25 mM MES, 100 uM EDTA, 10 uM sodium azide	95% H2O/5% D2O	0	5.5	ambient	298.15

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Varian	INOVA	800
3	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	X-PLOR NIH	2.10	Schwieters, Kuszewski, Tjandra and Clore
2	refinement	X-PLOR NIH	2.10	Schwieters, Kuszewski, Tjandra and Clore
3	structure solution	X-PLOR NIH	2.14	Schwieters, Kuszewski, Tjandra and Clore
4	refinement	X-PLOR NIH	2.14	Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.